Heart Failure Reviews

, Volume 16, Issue 3, pp 227–233 | Cite as

The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy

Article

Abstract

To date, cardiac resynchronization therapy remains the only treatment that enhances systolic function while improving long-term outcome and survival. Here, we review the molecular alterations associated with dyssynchronous heart failure and their reversibility induced by cardiac resynchronization therapy. We focus upon the molecular portrait of dyssynchronous heart failure and how cardiac resynchronization therapy influences electrophysiologic, metabolic and adrenergic pathways.

Keywords

Dyssynchronous heart failure Molecular portrait Gene expression Cardiac resynchronization therapy 

References

  1. 1.
    Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, European Society of Cardiology, European Heart Rhythm Association (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 9(10):959–998Google Scholar
  2. 2.
    Nelson GS, Berger RD, Fetics BJ, Talbot M, Hare JM, Spinelli JC, Kass DA (2000) Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102:3053–3059PubMedGoogle Scholar
  3. 3.
    Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549PubMedCrossRefGoogle Scholar
  4. 4.
    Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRefGoogle Scholar
  5. 5.
    Linde C, Leclercq Ch, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STImulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 3(40):111–118Google Scholar
  6. 6.
    Spragg DD, Kass DA (2006) Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 49(1):26–41PubMedCrossRefGoogle Scholar
  7. 7.
    Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J (1999) ffect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 99(23):2993–3001PubMedGoogle Scholar
  8. 8.
    Vanderheyden M, Bartunek J (2009) Cardiac resynchronization therapy in dyssynchronous heart failure: zooming in on cellular and molecular mechanisms. Circulation 119(9):1192–1194PubMedCrossRefGoogle Scholar
  9. 9.
    Van Oosterhout MF, Prinzen FW, Arts T, Schreuder JJ, Vanagt WY, Cleutjens JP, Reneman RS (1998) Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 98(6):588–595PubMedGoogle Scholar
  10. 10.
    Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW (2005) Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 26(1):91–98PubMedCrossRefGoogle Scholar
  11. 11.
    Prinzen FW, Vernooy K, DeBoeck BWL, Delhaas T (in press) Mechanoenergetics of the asynchronous and resynchronized heart. Heart Fail RevGoogle Scholar
  12. 12.
    Vernooy K, Cornelussen RN, Verbeek XA, Vanagt WY, van Hunnik A, Kuiper M, Arts T, Crijns HJ, Prinzen FW (2007) Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts. Eur Heart J 28(17):2148–2155PubMedCrossRefGoogle Scholar
  13. 13.
    Leclercq C, Kass DA (2002) Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39(2):194–201PubMedCrossRefGoogle Scholar
  14. 14.
    Gao Z, Barth AS, DiSilvestre D, Akar FG, Tian Y, Tanskanen A, Kass DA, Winslow RL, Tomaselli GF (2008) Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiol Genomics 35(3):222–230PubMedCrossRefGoogle Scholar
  15. 15.
    Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA (2003) Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108:929–932PubMedCrossRefGoogle Scholar
  16. 16.
    Baller D, Wolpers HG, Zipfel J, Bretschneider HJ, Hellige G (1988) Comparison of the effects of right atrial, right ventricular apex and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency: a laboratory investigation. Pacing Clin Electrophysiol 11(4):394–403PubMedCrossRefGoogle Scholar
  17. 17.
    Boerth RC, Covell JW (1971) Mechanical performance and efficiency of the left ventricle during ventricular stimulation. Am J Physiol 221(6):1686–1691PubMedGoogle Scholar
  18. 18.
    Bahler RC, Martin P (1985) Effects of loading conditions and inotropic state on rapid filling phase of left ventricle. Am J Physiol 48(42):523–533Google Scholar
  19. 19.
    Owen CH, Esposito DJ, Davis JW, Glower DD (1998) The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin Electrophysiol 21(7):1417–1429PubMedCrossRefGoogle Scholar
  20. 20.
    Leclercq C, Gras D, Le Helloco A, Nicol L, Mabo P, Daubert C (1995) Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 129(6):1133–1141PubMedCrossRefGoogle Scholar
  21. 21.
    Auricchio A, Prinzen FW (2008) Update on the pathophysiological basics of cardiac resynchronization therapy. Europace 10(7):797–800PubMedCrossRefGoogle Scholar
  22. 22.
    Mills RW, Cornelussen RN, Mulligan LJ, Strik M, Rademakers LM, Skadsberg ND, van Hunnik A, Kuiper M, Lampert A, Delhaas T, Prinzen FW (2009) Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency. Circ Arrhythm Electrophysiol 2(5):571–579PubMedCrossRefGoogle Scholar
  23. 23.
    Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, Halperin H, McVeigh E, Kass DA (2002) Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 106(14):1760–1763PubMedCrossRefGoogle Scholar
  24. 24.
    Prinzen FW, Peschar M (2002) Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 25(41):484–498PubMedCrossRefGoogle Scholar
  25. 25.
    Kass DA (2009) Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 6(11):1660–1665PubMedCrossRefGoogle Scholar
  26. 26.
    Sengupta PP, Tondato F, Khandheria BK, Belohlavek M, Jahangir A (2008) Electromechanical activation sequence in normal heart. Heart Fail Clin 4(3):303–314PubMedCrossRefGoogle Scholar
  27. 27.
    Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, Abraham TP, O’Rourke B, Akar FG, Kass DA, Tomaselli GF (2009) Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119(9):1220–1230PubMedCrossRefGoogle Scholar
  28. 28.
    Zabel M, Koller BS, Sachs F, Franz MR (1996) Stretch-induced voltage changes in the isolated beating heart: importance of the timing of stretch and implications for stretch-activated ion channels. Cardiovasc Res 32(1):120–130PubMedGoogle Scholar
  29. 29.
    Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF, Kass DA (2005) Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res 67(1):77–86PubMedCrossRefGoogle Scholar
  30. 30.
    Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL, Lardo AC, Abraham TP, Tomaselli GF, Kass DA (2008) Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117(11):1369–1377PubMedCrossRefGoogle Scholar
  31. 31.
    D’Ascia C, Cittadini A, Monti MG, Riccio G (2006) Saccà effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. Eur Heart J 27(2):201–206PubMedCrossRefGoogle Scholar
  32. 32.
    Bilchick KC, Saha SK, Mikolajczyk E, Cope L, Ferguson WJ, Yu W, Girouard S, Kass DA (2006) Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. Physiol Genomics 26(2):109–115PubMedCrossRefGoogle Scholar
  33. 33.
    Barth AS, Aiba T, Halperin V, DiSilvestre D, Khalid C, Dimaano VL, Yu W, Abraham T, Kass D, Tomaselli GF (2008) Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circulation 118:S_531Google Scholar
  34. 34.
    Mullens W, Bartunek J, Wilson Tang WH, Delrue L, Herbots L, Willems R, De Bruyne B, Goethals M, Verstreken S, Vanderheyden M (2008) Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients. Heart Rhythm 5(1):52–59PubMedCrossRefGoogle Scholar
  35. 35.
    Vanderheyden M, Mullens W, Delrue L, Goethals M, Verstreken S, Wijns W, De Bruyne B, Bartunek J (2008) Endomyocardial upregulation of betal adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail 14:172–178PubMedCrossRefGoogle Scholar
  36. 36.
    Chakir K, Daya SK, Aiba T, Tunin RS, Dimaano VL, Abraham TP, Lai EW, Pacak K, Zhu W, Xiao R, Tomaselli GF, Kass DA (2009) Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 119:1231–1240PubMedCrossRefGoogle Scholar
  37. 37.
    De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R (1999) Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85(1):68–76PubMedGoogle Scholar
  38. 38.
    Knaapen P, van Campen LM, Götte MJ, Visser CA, Lammertsma AA, Visser FC (2004) Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110(6):646–651PubMedCrossRefGoogle Scholar
  39. 39.
    Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, Samantapudi D, Paolocci N, Tomaselli GF, Kass DA, Van Eyk JE (2010) Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet 3(1):78–87PubMedCrossRefGoogle Scholar
  40. 40.
    Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117(20):2608–2616PubMedCrossRefGoogle Scholar
  41. 41.
    Abraham T, Kass D, Tonti G, Tomassoni GF, Abraham WT, Bax JJ, Marwick TH (2009) Imaging cardiac resynchronization therapy. JACC Cardiovasc Imaging 2(4):486–497PubMedCrossRefGoogle Scholar
  42. 42.
    Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT (2007) Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. J Card Fail 13(4):304–311PubMedCrossRefGoogle Scholar
  43. 43.
    Vanderheyden M, Mullens W, Delrue L, Goethals M, De Bruyne B, Wijns W, Geelen P, Verstreken S, Wellens F, Bartunek J (2008) Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51(2):129–136PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marc Vanderheyden
    • 1
  • Chris Vrints
    • 1
    • 2
  • Jozef Bartunek
    • 1
  1. 1.Cardiovascular Center, Onze Lieve VrouwziekenhuisAalstBelgium
  2. 2.Department of CardiologyUniversity of AntwerpAntwerpBelgium

Personalised recommendations